BOSTON--(BUSINESS WIRE)--inviCRO, a Boston-based imaging services and informatics company, was named to the Inc. Magazine’s 2014 Inc. 500|5000, cracking the top 700 with a three year growth rate of 687%. In addition to being named one of fastest growing private companies in the United States, inviCRO landed as the 20th fastest growing company in the Boston metro area. The annual announcement marks inviCRO’s second consecutive inclusion on the list (No. 327 in 2013), an honor held by some of America’s best recognized companies.
“We’re thrilled to be included on the Inc. 500|5000 for the second time,” says inviCRO’s Co-Founder and Managing Director, Jack Hoppin, Ph.D. “This achievement reflects the expansion of our customer relationships and the continued leveraging of our specialized services to advance drug development programs. Most importantly, we are incredibly thankful to all of the researchers we work with both in industry and academia. Their drive and their research projects are the inspiration for all of the developments we have made in the field of translational multi-modal imaging.”
inviCRO is a leading provider of translational imaging services, image analysis, data management and software solutions. inviCRO continues to sustain substantial growth in 2014 with the launch of a multi-modality imaging facility in Boston’s Innovation District and the addition of 20 employees from a broad array of scientific disciplines. Additionally, inviCRO co-developed and co-manages a new state-of-the-art cyclotron facility in Mattawan, MI in partnership with MPI Research and 3D Imaging. inviCRO’s contribution to the multimillion-dollar facility, which will provide fully translational molecular imaging services, highlights the company’s specialized strength in using bioinformatics to solve complex problems in drug discovery and development.
About inviCRO:
inviCRO is an imaging informatics company offering full-service tissue-to-human imaging, analysis and data management services powered by their industry-leading software platforms. In addition to their multi-modality imaging facility in Boston’s Innovation District, inviCRO’s services are delivered through a network of validated partners highlighted by the co-managed cyclotron facility at the Translational Imaging Center (inviCRO, MPI Research, 3DI). inviCRO’s image processing suite (VivoQuant™) and data management platform (iPACS®) are used by a majority of the top 25 pharmaceutical companies. The interdisciplinary team of inviCRO scientists have managed and/or processed 500+ imaging trials across a broad spectrum of therapeutic areas.